Program

Preliminary Program

Thursday, 13 February 2020

08:00-09:00

Registration 

08:50

Conference Opening Welcome
Marina de Tommaso, Italy – Conference Chair

09:00-10:30

Session I: May We Predict Clinical Phenotypes?

 09:00-09:30

Clinical Phenotypes: Registry – Enroll Studies
Georg Bernhard Landwehrmeyer, Germany

09:30-10:00

Prodromal Phase of Huntington’s Disease 
Caterina Mariotti, Italy

10:00-10:30

Huntington’s Disease Like Disorders 
Giuseppe De Michele, Italy

10:30-11:00

Coffee Break

11:00-12:30

Session II: May We Predict Clinical Outcome by Cognitive Assessment?  

11:00-11:30

The Burden of Cognitive Decline in Pre-symptomatic Huntington’s Disease
Andrea Horta Barba, Spain

11:30-12:00

Virtual Reality as a Tool to Predict the Functional Impact of Executive Deficits
Filipa Júlio, Portugal

12:00-12:30

Theory of Mind in Huntington’s Disease
Marianna Delussi, Italy

12:30-13:30

Lunch Break

13:30-15:00

Session III: Easily Accessible Biomarkers?

13:30-14:00

Imaging and Wet Biomarkers
Elena Salvatore, Italy

14:00-14:30

Neurophysiological features in pre-symptomatic and early Huntington’s Disease
Marianna Delussi, Italy

14:30-15:00

Cortical Biomarkers of Huntington's Disease: A Multicentric TMS-EEG Study
Elias P Casula, Italy

15:00-15:30

Coffee Break  

15:30-17:00

Session IV:  Can We Improve Huntington’s Disease Outcome by Symptomatic Treatments?

15:30-16:00

Current Treatments in Huntington’s Disease 
Georg Bernhard Landwehrmeyer, Germany

16:00-16:30

Depression and Behavior Disorders
Sandro Sorbi, Italy

16:30-17:00

Motor Gpi Deep Brain Stimulation For Huntington’s Disease: Long-Term Results
Philippe Coubes, France




Friday, 14 February 2020

08:00-09:00

Registration 

09:00-10:30

Do HD Patients Suffer from Chronic Pain?  

 09:00-09:30

The Challenge of Pain Diagnosis in Dementia
Lydia Giménez-Llort, Spain

09:30-10:00

Prevalence of Pain in Huntington’s Disease
Wilco Achterberg
, The Netherlands

10:00-10:30

Neurophysiological Basis Of “Pain or No Pain” In Huntington’s Disease
Marina de Tommaso, Italy

10:30-11:00

Coffee Break

11:00-12:30

Session VI: Which Role for Non-Pharmacologic Approach?

11:00-11:30

Physical Therapy: When, Where and How
Herwig Lange, Germany

11:30-12:00

Evidence for a Logopedic Approach
Angela Nuzzi, Italy

12:00-12:30

Customized Dietary Intervention Avoids Unintentional Weight Loss and Modulates Circulating miRNAs Footprint in Huntington's Disease
Nieves González Gómez, Spain

12:30-13:30

Lunch Break

13:30-15:00

Session VII:  The Role of Placebo and Alternative Medicine in Huntington’s Disease

13:30-14:00

Biological Properties of Placebo and Global Advantage in Clinical Trials
Marina de Tommaso, Italy

14:00-14:30

Alternative Medicine in Huntington’s Disease: Only Placebo Effect?
Daniel Zielonka, Poland

14:30-15:00

Vitamins and Integrators
Jiri Klempir, Czech Republic

15:00-15:30

Coffee Break  

15:30-17:10

Session VIII:  Are There Realistic Treatment Perspectives in Huntington’s Disease?

15:30-16:00

ASO Phase III: State of The Art
TBA

16:00-16:30

The Good and The Bad Huntington’s
TBA

16:30-17:00

Other Promising Treatments
TBA

17:00-17:10

Closing Remarks
Marina de Tommaso, Italy – Conference Chair